Lille, France; Cambridge, MA; July 08, 2022 - GENFIT (NasdaqandEuronext:GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.
Read more at globenewswire.comGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here